- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Featured Content
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Unpacking Amgen v. Sanofi
Aug 31st 2023
Exploring the state of pharma patents following the Supreme Court’s Amgen v. Sanofi decision.
Latest Videos
Latest News
Bright Path Laboratories to Collaborate in NSF Engines Development Program
May 16th 2023
The NSF-sponsored program aims to help partners collaborate to create opportunities for significant economic, societal, and technological opportunities for growth in their regions.
Amgen and Tscan Therapeutics Team Up to Identify Novel Targets in Crohn's Disease
May 12th 2023
In a deal potentially worth more than $530 million, Amgen will use TScan Therapeutics’ target discovery platform to home in on novel targets for Crohn’s disease treatment.
Sandoz and Just – Evotec Biologics Form Biosimilars Pact
May 12th 2023
The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.
.webp?w=350&fit=crop&auto=format)
Baxter Divests BioPharma Solutions Department in $4.25 Billion Deal
May 10th 2023
Private investors from Advent International and Warburg Pincus will operate the assets as an independent CDMO.
Ginkgo Bioworks and Boehringer Ingelheim Sign $405 Million Drug Discovery Deal
May 9th 2023
Boehringer Ingelheim will use Ginkgo’s metagenomic sequence database to identify potential lead molecules for diseases with high unmet patient needs.
Aspect Biosystems, Novo Nordisk Partner to Develop Bioprinted Tissue Therapeutics
April 25th 2023
Aspect Biosystems and Novo Nordisk A/S have announced a collaboration, development, and license agreement to develop bioprinted tissue therapeutics.